{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:45:39Z","timestamp":1769064339234,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jneuroim.2018.06.013","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T02:50:23Z","timestamp":1532400623000},"page":"119-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Fulminant Anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression"],"prefix":"10.1016","volume":"323","author":[{"given":"J.","family":"Triplett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vijayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Lawn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"McLean-Tooke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bynevelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Phatouros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Chemmanam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2018.06.013_bb0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13760-015-0493-1","article-title":"Anti-GAD antibodies, a rare cause of limbic encephalitis: a case report","volume":"116","author":"Ael","year":"2016","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/347151a0","article-title":"Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase","volume":"347","author":"Baekkeskov","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10072-009-0122-y","article-title":"Epilepsia partialis continua in type 1 diabetes: evolution into epileptic encephalopathy with continuous spike-waves during slow sleep","volume":"30","author":"Baglietto","year":"2009","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0020","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","article-title":"GABAB receptor antibodies in limbic encephalitis and anti-GAD-associated neurological disorders","volume":"76","author":"Boronat","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neurad.2016.12.008","article-title":"Serial MRI images of unusual presentation of anti-GAD encephalitis: A new pattern?","volume":"44","author":"Bougea","year":"2017","journal-title":"J. Neuroradiol."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0035","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1212\/WNL.57.5.780","article-title":"Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies","volume":"57","author":"Dalakas","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ana.25002","article-title":"A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome","volume":"82","author":"Dalakas","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12883-015-0435-9","article-title":"Long latency between GAD-antibody detection and development of limbic encephalitis \u2013 a case report","volume":"15","author":"Fauser","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1941875211413135","article-title":"Autoimmune Limbic Encephalitis with GAD Antibodies","volume":"1","author":"Finelli","year":"2011","journal-title":"Neurohospitalist."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0055","series-title":"Autoimmune dementia and encephalopathy in Handbook of Clinical Neurology","volume":"133","author":"Flanagan","year":"2016"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0060","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.61.6.938","article-title":"Stiff-person syndrome following West Nile fever","volume":"61","author":"Hassin-Baer","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0065","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1212\/01.wnl.0000196488.87746.7b","article-title":"Paraneoplastic encephalomyelitis with pancreatic tumor and anti-GAD antibodies","volume":"66","author":"Hernandez-Echebarria","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0070","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.clineuro.2009.06.005","article-title":"Stiff person syndrome associated with lower motor neuron disease and infiltration of cytotoxic T cells in the spinal cord","volume":"111","author":"Holomy","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00185772","article-title":"Distribution of GABA-containing neurons in human frontal cortex: a quantitative immunocytochemical study","volume":"189","author":"Hornung","year":"1994","journal-title":"Anat. Embryol."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0080","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1073\/pnas.1001074107","article-title":"Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arteritis","volume":"107","author":"Huang","year":"2010","journal-title":"PANS."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0085","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1528-1167.2007.01500.x","article-title":"Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus","volume":"49","author":"Kanter","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0090","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0095","doi-asserted-by":"crossref","unstructured":"Meinck HM, Faber L, Morgenthaler N, Seissler J, Butler M, Solimena M, DeCamilli P. Scherbaum WA. Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases. J. Neurol. Neurosurg. Psychiatry 2001;71:100\u20133.","DOI":"10.1136\/jnnp.71.1.100"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with therapy resistant epilepsy","volume":"55","author":"Peltola","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1172\/JCI10860","article-title":"Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs","volume":"107","author":"Pugliese","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010838","article-title":"Long-Lived Plasma Cells and Memory B Cells Produce Pathogenic Anti-GAD65 Autoantibodies in Stiff Person syndrome","volume":"5","author":"Rizzi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0115","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756285617722347","article-title":"Treatment stratergies for autoimmune encephalitis","volume":"11","author":"Shin","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0125","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0166-2236(91)90044-U","article-title":"Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus","volume":"14","author":"Solimena","year":"1991","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0130","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/j.1528-1167.2010.02644.x","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels","volume":"51","author":"Stagg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0135","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1158\/1078-0432.CCR-04-0735","article-title":"Autoantibody profiles and neurological correlations of thymoma","volume":"10","author":"Vernino","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/08916930701619565","article-title":"Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-GAD antibodies","volume":"41","author":"Vianello","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/WCO.0000000000000304","article-title":"Progress in autoimmune epileptic encephalitis","volume":"29","author":"Wright","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2018.06.013_bb0150","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1523\/JNEUROSCI.1970-16.2016","article-title":"Dorsolateral Prefrontal Cortex GABA Concentration in Humans Predicts Working Memory Load Processing Capacity","volume":"36","author":"Yoon","year":"2016","journal-title":"J. Neurosci."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818302200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818302200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:33:01Z","timestamp":1759048381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818302200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":30,"alternative-id":["S0165572818302200"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.06.013","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fulminant Anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}